Agreement and Collaboration was the Key Growth Strategy in the PEGylated Proteins Market
PEGylated proteins products include consumables and services mainly used for cancer treatment, hepatitis, chronic kidney diseases, haemophilia, multiple sclerosis, and gastrointestinal disorders.
The global PEGylated proteins market was dominated by Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and NOF Corporation (Japan) in 2016. With a broad product portfolio and collaborations...